Literature DB >> 15495238

Proportion of drug-related serious rare blood dyscrasias: estimates from the Berlin Case-Control Surveillance Study.

Frank Andersohn1, Elisabeth Bronder, Andreas Klimpel, Edeltraut Garbe.   

Abstract

Drugs are an important cause of serious rare blood dyscrasias. To estimate the proportion of drug-related cases, we used data from the ongoing Berlin Case-Control Surveillance Study. The analysis included a total of 171 cases. The number of cases in which a drug etiology was assessed as at least "possible" was n = 29 (97%) for acute agranulocytosis, n = 4 (0.21%) for aplastic anemia, n = 8 (26%) for immune hemolytic anemia, n = 20 (25%) for immune thrombocytopenia, and n = 2 (20%) for thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Our analysis suggests that a substantial fraction of blood dyscrasias may be attributable to drug therapy.

Entities:  

Mesh:

Year:  2004        PMID: 15495238     DOI: 10.1002/ajh.20176

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  8 in total

1.  [Adverse drugs reactions: diagnosis and assessment].

Authors:  P A Thürmann
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

2.  Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals.

Authors:  N Tavassoli; E Duchayne; B Sadaba; K Desboeuf; A Sommet; M Lapeyre-Mestre; M J Muoz; P Sie; J Honorato; J L Montastruc; H Bagheri
Journal:  Eur J Clin Pharmacol       Date:  2007-01-17       Impact factor: 2.953

3.  Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study.

Authors:  Edeltraut Garbe; Frank Andersohn; Elisabeth Bronder; Abdulgabar Salama; Andreas Klimpel; Michael Thomae; Hubert Schrezenmeier; Martin Hildebrandt; Ernst Späth-Schwalbe; Andreas Grüneisen; Oliver Meyer; Hanife Kurtal
Journal:  Eur J Clin Pharmacol       Date:  2011-12-21       Impact factor: 2.953

4.  Flupirtine-induced liver injury--seven cases from the Berlin Case-control Surveillance Study and review of the German spontaneous adverse drug reaction reporting database.

Authors:  Antonios Douros; Elisabeth Bronder; Frank Andersohn; Andreas Klimpel; Michael Thomae; Hans-Dieter Orzechowski; Reinhold Kreutz; Edeltraut Garbe
Journal:  Eur J Clin Pharmacol       Date:  2013-12-24       Impact factor: 2.953

5.  Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura: a report from the SERF-TTP Research Group and the RADAR Project.

Authors:  Charles L Bennett; Benjamin Kim; Anaadriana Zakarija; Nicholas Bandarenko; Dilip K Pandey; Charlie G Buffie; June M McKoy; Amul D Tevar; John F Cursio; Paul R Yarnold; Hau C Kwaan; Davide De Masi; Ravindra Sarode; Thomas J Raife; Joseph E Kiss; Dennis W Raisch; Charles Davidson; J Evan Sadler; Thomas L Ortel; X Long Zheng; Seiji Kato; Masanori Matsumoto; Masahito Uemura; Yoshihiro Fujimura
Journal:  J Am Coll Cardiol       Date:  2007-09-04       Impact factor: 24.094

Review 6.  Drug-induced thrombosis: an update.

Authors:  Yuval Ramot; Abraham Nyska; Galia Spectre
Journal:  Drug Saf       Date:  2013-08       Impact factor: 5.606

Review 7.  State of Art of Idiosyncratic Drug-Induced Neutropenia or Agranulocytosis, with a Focus on Biotherapies.

Authors:  Emmanuel Andrès; Noel Lorenzo Villalba; Abrar-Ahmad Zulfiqar; Khalid Serraj; Rachel Mourot-Cottet; And Jacques-Eric Gottenberg
Journal:  J Clin Med       Date:  2019-09-01       Impact factor: 4.241

8.  Combination of strategies to initiate clozapine for refractory schizophrenia in a patient with low neutrophil levels.

Authors:  Keisuke Takanobu; Naoki Hashimoto; Shuhei Ishikawa; Ichiro Kusumi
Journal:  BMJ Case Rep       Date:  2022-10-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.